You want to know what separates a well-run franchise from the rest of baseball? It usually isn't the $155 million splash. It's the quiet paperwork nobody tweets about.
Baltimore just handed Yennier Cano a two-year extension for 2027 and 2028, worth $7.5 million total, with a $10 million club option for 2029. It was announced Friday, July 31. A front office quietly stapled its best reliever to the roster before the open market ever got a whiff of him.
It's a terrific deal.
The math is almost unfair
The structure: $2.75 million in 2027, $4.75 million in 2028, which would have been Cano's final arbitration year under the current CBA. Then a $10 million option for 2029 that can climb by another $3 million based on games finished in 2028. In plain terms, the Orioles bought out his remaining arbitration years and got themselves a cheap option on a third season. The Orioles aren't mortgaging free-agent years on a reliever here, which is the fastest way for a team to regret itself in three summers. What they bought instead is cost control with an escape hatch.
Now look at what they bought. Entering that Friday, Cano carried a 2.21 ERA across 48 appearances in 2026, probably the best arm in Baltimore's bullpen. The 32-year-old Cuban righty made the All-Star team back in 2023 with a 2.11 ERA over 72 outings. For his career he's 11-17 with a 3.78 ERA and 16 saves in 268 games, nearly all of them in orange and black.
Relievers pitching like that don't stay affordable for long. One more strong season and his arbitration number balloons. Baltimore didn't wait around for the price to move.
They didn't buy a perfect résumé
The skeptics have a point worth answering. Cano was rough in 2025: a 5.12 ERA in 65 appearances, a career-high 24 walks, the most home runs he'd ever allowed. If you squint, you could argue his leverage wasn't about to explode, that Baltimore wasn't buying low so much as betting on a bounce-back.
But faith backed by your own development staff is the whole business of running a farm system. The Orioles got Cano in the 2022 trade that sent Jorge Lopez to Minnesota, a deal that also netted them pitcher Cade Povich. They turned a middle-innings arm into an All-Star, watched him stumble, and bet on the version they helped build rather than the version that scared everyone else off. That's the chain a good organization runs: shrewd trade, patient development, cheap extension. Owner David Rubenstein, whose group bought the team in March 2024, put it plainly, crediting Mike Elias and his staff's "ability to identify talent inside and outside the organization." Self-congratulatory, maybe. Still true.
The deadline made it look even better
Here's what turned a good move into a clever one. When Cano signed, Baltimore was 53-56, sitting 2.5 games out of the final AL Wild Card spot, and Elias wasn't pretending otherwise. "We're 2.5 out," he said Friday. "We're 3 games below .500. I think both of those are really disappointing."
Three days later, at the August 3 deadline, the Orioles sold. Taylor Ward went to Seattle. Dean Kremer and Adley Rutschman were dealt to Minnesota and Boston. Tyler Wells, another arm controlled through 2027, was shipped to Tampa Bay. While they were subtracting pieces, they kept the reliever they'd just made cheap. In the days since, it's been Cano and Andrew Kittredge getting the back-to-back high-leverage chances Wells used to soak up. The extension already looks smarter in practice than it did on paper, though that's only a few days of evidence, so let's not get carried away.
Cano, for his part, wanted to stay. When his agent asked, the answer was "100 percent."
Boring wins
The Cano deal fits a pattern. It's the fourth Orioles extension in about a year, joining catcher Samuel Basallo (eight years, $67 million), and starters Shane Baz (five years, $68 million) and Kyle Bradish (five years, $90 million), on top of the Pete Alonso free-agent deal worth $155 million over five years. Some of those are big swings. This one isn't. It's the small, disciplined move that never trends.
Anybody can spend $155 million. Recognizing a 2.21 ERA at reliever prices and locking it in before the market catches up takes an organization that actually knows what it's holding. Two years from now, $7.5 million for these seasons of Cano is going to look like a steal, and the teams still overpaying for other people's late-inning arms will wish they'd done the boring thing first.
